Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in Korea

• Main Authors: Hyesoo Cho (Author), Ye-Jee Kim (Author), Ik Jun Moon (Author), Woo Jin Lee (Author), Chong Hyun Won (Author), Mi Woo Lee (Author), Sung Eun Chang (Author), Joon Min Jung (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

AbstractPurpose Few studies have investigated the impact of biologics on the risk of major adverse cardiovascular events (MACEs) among Korean patients with psoriatic diseases. We compared the risk of MACEs and all-cause mortality among patients with psoriatic disease treated with tumor necrosis fact...